Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Net Letter
ARTICLE IN PRESS
doi:
10.25259/IJDVL_726_2024

Drug reaction with eosinophilia and systemic symptoms with toxic epidermal necrolysis like rash in systemic sclerosis and overlapping sjogren’s syndrome: A double trouble triggered by a herbal medicine

Department of Dermatology Venereology and Leprosy, Sri Manakula Vinayagar Medical College & Hospital, Madagadipet, Kalitheerthalkuppam, Pondicherry, India.

Corresponding author: Dr. Logamoorthy R, Department of Dermatology Venereology and Leprosy, Sri Manakula Vinayagar Medical college & Hospital, Madagadipet, Kalitheerthalkuppam, Pondicherry, India. logamoorthy.r@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Youvalakshmi S, Logamoorthy R, Karthikeyan K. Drug reaction with eosinophilia and systemic symptoms with toxic epidermal necrolysis like rash in systemic sclerosis and overlapping sjogren’s syndrome: A double trouble triggered by a herbal medicine. Indian J Dermatol Venereol Leprol. doi: 10.25259/IJDVL_726_2024

Dear Editor,

Toxic epidermal necrolysis (TEN) is a severe cutaneous adverse reaction characterised by extensive full-thickness skin and mucous membrane necrosis, resulting in widespread exfoliation and possible sepsis. TEN-like presentations, associated with auto-immune diseases, are more commonly reported with acute lupus erythematosus and less likely with systemic sclerosis.1 TEN-like manifestations in connective tissue disorders and drug-induced TEN are clinically indistinguishable. Hence, a high index of suspicion is important as the prognosis of the disease will be altered by early diagnosis and prompt management. In this case report, we present a case of drug-induced TEN in a patient with systemic sclerosis.

A 33-year-old female, a known case of systemic sclerosis since the past two years, presented with reddish raised lesions all over the body with facial oedema and oral erosions for 20 days following the intake of a native medication (Smilax china). She was on irregular treatment with methotrexate and nicardipine for systemic sclerosis for the past one year. On cutaneous examination, the patient had a diffuse maculopapular rash over the anterior and posterior trunk, upper limb, neck and bilateral thighs, suggesting a drug-induced exanthem [Figures 1a and 1b]. The clinical and laboratory findings are tabulated in Table 1. The complete hemogram revealed anaemia with a haemoglobin level of 9.8 g/dL (12–15 g/dL), a white blood cell count of 6200 cells/cu.mm (4000–11000 cells/cu.mm) with 8% (0–6%) eosinophilia, a platelet count of 373,000 cells/cu.mm (1,50,000–4,50,000 cells/cu.mm). The liver function test showed elevated Aspartate aminotransferase (AST) at 50 IU/L (Normal: 0–35 IU/L) and Alanine aminotransferase (ALT) at 331 IU/L (Normal: 0–35 IU/L). A diagnosis of probable DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) was made due to the presence of eosinophilia and hepatitis, with a Regiscar score of 4. The patient was admitted and started on oral prednisolone (0.5 mg/kg) and IV ceftriaxone 1 g once daily for heavy Escherichia.coli growth in vaginal swabs taken from erosions over the vaginal mucosa. After two days, the lesions progressed to vesiculobullous eruptions with epidermal detachment all over the body. On examination, multiple vesicles and bulla were present all over the body, with sheets of necrosis and spots seen over the trunk and extremities [Figures 2a and 2b]. The biopsy from the posterior trunk showed subepidermal blister formation containing lymphocytes, macrophages and occasional acantholytic cells along with RBCs and eosinophilic fluid. The superficial dermis shows minimal dermal oedema with mild perivascular and periadnexal inflammatory infiltrate composed of lymphocytes and plasma cells within a thick, dense collagenised stroma suggestive of systemic sclerosis with toxic epidermal necrolysis [Figure 3]. The Naranjo score was 5, indicating a probable causal relationship between the drug and toxic epidermal necrolysis.2 Ceftriaxone was stopped in view of worsening of pre-existing drug rash, following which the lesions stopped progressing after 48 hours. High resolution computed tomography (HRCT) showed bilateral basal sub-pleural honeycombing, which was indicative of interstitial lung disease. The patient was treated with dexamethasone 8 mg once daily for 6 days and the patient was later switched to oral prednisolone 40 mg once daily at the time of discharge, with mycophenolate mofetil 500 mg twice daily, nintedanib 100 mg twice daily and doxophylline 200 mg twice daily.

Woman with systemic sclerosis with diffuse maculopapular rash following intake of herbal medicine (Smilax china) (a) over the face with chapped lips and (b) over the trunk.
Figure 1:
Woman with systemic sclerosis with diffuse maculopapular rash following intake of herbal medicine (Smilax china) (a) over the face with chapped lips and (b) over the trunk.
Table 1: Summary of clinical and laboratory investigation for diagnosis of systemic sclerosis
Clinical Manifestations and Investigations
Face Elongated face, pinched nose, pursed lips and flattening of the nasolabial fold
Cutaneous examination Skin thickening and tightening of the face and extremities, salt-and-pepper pigmentation over the flexural aspect and nape of the neck and right forearm.
Oral cavity Restriction of mouth opening and perioral furrowing
Hand Pitted scars over the fingertips and sclerodactyly
Positive signs Ingram’s sign and Barnet’s neck sign
Modified Rodnan Skin Score (MRSS) 17/51
Nailfold capillaroscopy Drop outs present with few haemorrhages
EULAR criteria (2013) 19
ANA (Indirect Immunofluorescence)

4+ homogenous pattern (1:80 dilution)

Positive for anti-Scl-70, anti-RO & anti-SSA antibodies

EULAR: European Alliance of Associations for Rheumatology, RO: ribonucleoprotein, SSA: Sjogren’s syndrome antibody.

(a) Confluent vesicles and bullae over the trunk with sheets of necrosis on a background of erythema and (b) oral erosions with haemorrhagic and dried up crust over the lips and perioral area suggestive of toxic epidermal necrolysis.
Figure 2:
(a) Confluent vesicles and bullae over the trunk with sheets of necrosis on a background of erythema and (b) oral erosions with haemorrhagic and dried up crust over the lips and perioral area suggestive of toxic epidermal necrolysis.
Subepidermal blister with basket weave orthokeratosis, apoptotic keratinocytes with dense lymphocytic infiltrate in the superficial dermis, dermal oedema, and dense collagenised stroma (Haematoxylin and eosin, 400x)
Figure 3:
Subepidermal blister with basket weave orthokeratosis, apoptotic keratinocytes with dense lymphocytic infiltrate in the superficial dermis, dermal oedema, and dense collagenised stroma (Haematoxylin and eosin, 400x)

Systemic sclerosis is an autoimmune disease that causes fibrosis of the skin and internal organs with associated microvascular damage. Bullous lesions in systemic sclerosis are a rare manifestation. It can occur due to several pathologic mechanisms like drug-induced, autoimmune, secondary to fibrosis and lymphatic obstruction.3,4 TEN is a dreaded condition resulting in widespread blistering eruptions. TEN-like lesions are more likely to occur in patients with connective tissue disease as in TEN-like acute and subacute cutaneous lupus erythematosus. Aiempanakit et al. described a patient with systemic sclerosis developing TEN-like cutaneous lupus erythematosus.5 In our case, the patient was diagnosed with drug-induced TEN with systemic sclerosis and secondary Sjogren syndrome. The difference between TEN associated with connective tissue disease and drug-induced TEN is shown in Table 2. However, these differences are subjective and theoretical.6,7 The primary therapy for drug-induced TEN is the withdrawal of the culprit drug followed by barrier nursing, wound care, fluid and electrolytes correction, analgesic support and intensive care for systemic complications. Other treatment options include systemic corticosteroids, cyclosporine, IV immunoglobulins and plasma exchange. Further, the active ingredient of the native medication is the herb Smilax china. We have performed a literature search for drug rash due to smilax china but were unable to find any TEN or DRESS reported previously to smilax china. It is a popular herb used in Siddha, Ayurveda and Chinese medicine. It is to be remembered that such serious adverse reactions can occur with herbal medications as well.

Table 2: Comparison of TEN versus TEN-like presentation in connective disorder
TEN TEN associated with CTD
Pathophysiology

Genetical predisposition in special haplotypes, HLAB *1502 and HLA B*5801

Activation of soluble Fas ligand pathway

Increased granulysin and perforin

Depends on the underlying connective tissue disorder:

Lupus Erythematosus: ultraviolet rays-induced apoptosis and necrosis; increases CCL27 (activation of autoimmune T cells)

Systemic Sclerosis: bullous lesions are a rare entity

History History of high-risk drug intake No drug history
Sex predominance Female>male (1.5:1) Female>male (9:1)
Mucosal involvement Severe Mild while compared to drug-induced TEN
Laboratory Negative for LE-related antibodies ANA +, ds DNA +, C3 and C4
Histopathology Interface dermatitis, along with vacuolar basal cell degeneration and scattered necrotic keratinocytes in the epidermis Epidermal necrosis involving the entire epidermis, vacuolar degeneration of basal keratinocytes
Direct IF Negative Dense granular IgM, IgA and C3 deposits along the dermo-epidermal junction.
Management Stop culprit drug, shorter course of steroids, cyclosporine, IVIG and plasmapheresis Steroids (long duration) and immunosuppressants

CTD: connective tissue disease, HLA B: Human Leukocyte Antigen B, ANA: antinuclear antibodies, ds DNA: double-stranded deoxyribonucleic acid, IF: immunofluorescence, IVIG: intravenous immunoglobulin.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

References

  1. , , . Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19:1050-70.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , . Causality assessment of cutaneous adverse drug reactions. Ann Dermatol. 2011;23:432-8.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , . Bullous lesions in scleroderma. Int J Dermatol. 2002;41:335-9.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , . Diffuse systemic sclerosis with bullous lesions without systemic manifestations. An Bras Dermatol. 2013;88:78-81.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  5. , , , . Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus in a patient with progressive systemic sclerosis. Lupus. 2018;27:1860-3.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , . Association of antinuclear antibodies with toxic epidermal necrolysis – A novel manifestation. East J Med Sci. 2020;5:61-5.
    [Google Scholar]
  7. , , , . Toxic epidermal necrolysis like acute cutaneous lupus erythematous or drug-induced toxic epidermal necrolysis: a case report of a diagnostic dilemma. Int J Res Dermatol. 2020;6:563-6.
    [Google Scholar]

Fulltext Views
1,613

PDF downloads
11
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections